XAMINE-CR Trademark

Trademark Overview

On Friday, June 6, 2008, a trademark application was filed for XAMINE-CR with the United States Patent and Trademark Office. The USPTO has given the XAMINE-CR trademark a serial number of 79055601. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, June 6, 2018. This trademark is owned by Solvay Pharmaceuticals B.V.. The XAMINE-CR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, psycho-active drugs for the treatment of anxiety, depression and obsessive-compulsive disorders
xamine-cr

General Information

Serial Number79055601
Word MarkXAMINE-CR
Filing DateFriday, June 6, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, June 6, 2018
Registration Number3651337
Registration DateTuesday, July 7, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances, namely, psycho-active drugs for the treatment of anxiety, depression and obsessive-compulsive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbott Products Operations AG
Party Type32 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressCH
Party NameAbbott Healthcare Products B.V.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressNL
Party NameSolvay Pharmaceuticals B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNL
Party NameSolvay Pharmaceuticals B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNL
Party NameSolvay Pharmaceuticals B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events

Event DateEvent Description
Friday, January 4, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, January 4, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, March 24, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, January 10, 2017GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, January 10, 2017GENERIC MADRID TRANSACTION CREATED
Wednesday, October 12, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 12, 2016CANCELLED SECTION 71
Saturday, April 27, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 9, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 18, 2013CHANGE OF OWNER RECEIVED FROM IB
Friday, December 21, 2012NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, June 6, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 27, 2010CHANGE OF OWNER RECEIVED FROM IB
Friday, November 13, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 16, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 16, 2009FINAL DISPOSITION PROCESSED
Wednesday, October 7, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 7, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Wednesday, March 18, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 16, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 16, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 17, 2009ASSIGNED TO LIE
Monday, March 16, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 7, 2008REFUSAL PROCESSED BY IB
Thursday, September 18, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 18, 2008REFUSAL PROCESSED BY MPU
Thursday, September 18, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 17, 2008NON-FINAL ACTION WRITTEN
Wednesday, September 17, 2008ASSIGNED TO EXAMINER
Friday, August 1, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, July 31, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xamine depression anxiety obsessive compulsive disorders treatment drugs substances preparations namely